14.12.2021 18:30:32
|
EQS-Adhoc: Achiko completes share capital increase
EQS-Ad-hoc: Achiko AG / Key word(s): Miscellaneous Achiko completes share capital increase Zurich, 14 December 2021: Ad hoc announcement pursuant to Art. 53 LR - Achiko AG (SWX: ACHI, ISIN CH0522213468) announces that its share capital recorded in the commercial register has been increased by 10,081,666 shares to 118,985,566 shares to satisfy claims from a share lending relied on in connection with a private placement. The new shares have been issued out of the existing authorized capital. ABOUT ACHIKO AG AptameX comprises of DNA aptamer-based technology that is cost-effective, chemically synthesised and widely applicable to the evolving diagnostic field of healthcare. Together with the digital mobile health app Teman Sehat, Achiko is developing potential technologies that seek to deliver rapid, affordable diagnostic testing for a range of pathogenic diseases and therapeutic indications. The AptameX technology is licensed from Regenacellx.sl and Achiko has exclusive commercialisation rights. Headquartered in Zurich, Achiko has offices in Hong Kong, Jakarta, Seoul and Singapore. Further information can be found at www.achiko.com. Media contacts: Switzerland & Global
Disclaimer End of ad hoc announcement |
Language: | English |
Company: | Achiko AG |
Tessinerplatz 7 | |
8002 Zurich | |
Switzerland | |
E-mail: | ir@achiko.com |
Internet: | https://www.achiko.com/ |
ISIN: | CH0522213468 |
Valor: | 48788430 |
Listed: | SIX Swiss Exchange |
EQS News ID: | 1257797 |
End of Announcement | EQS News Service |
|
1257797 14-Dec-2021 CET/CEST
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Achiko AGmehr Nachrichten
Keine Nachrichten verfügbar. |